Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, February 2001, p. 428-432, Vol. 45, No. 2
Department of Microbiology, Colorado State
University, Fort Collins, Colorado 80523-1677,1
and Department of Biological Sciences, University of
Calgary, Calgary, Alberta, Canada T2N 1N42
Received 3 July 2000/Returned for modification 7 September
2000/Accepted 31 October 2000
Triclosan is an antiseptic frequently added to items as diverse as
soaps, lotions, toothpaste, and many commonly used household fabrics
and plastics. Although wild-type Pseudomonas aeruginosa expresses the triclosan target enoyl-acyl carrier protein reductase, it
is triclosan resistant due to expression of the MexAB-OprM efflux
system. Exposure of a susceptible
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.2.428-432.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cross-Resistance between Triclosan and Antibiotics in
Pseudomonas aeruginosa Is Mediated by Multidrug Efflux
Pumps: Exposure of a Susceptible Mutant Strain to Triclosan
Selects nfxB Mutants Overexpressing
MexCD-OprJ
(mexAB-oprM) strain to
triclosan selected multidrug-resistant bacteria at high frequencies. These bacteria hyperexpressed the MexCD-OprJ efflux system due to
mutations in its regulatory gene, nfxB. The MICs of several drugs for these mutants were increased up to 500-fold, including the
MIC of ciprofloxacin, which was increased 94-fold. Whereas the
MexEF-OprN efflux system also participated in triclosan efflux, this
antimicrobial was not a substrate for MexXY-OprM.
*
Corresponding author. Mailing address: Department of
Microbiology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-3536. Fax: (970) 491-1815. E-mail:
hschweiz{at}cvmbs.colostate.edu.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |